Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 2Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 149INDUSTRY 47NIH 37NETWORK 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 2Refractory Differentiated Thyroid Gland Carcinoma 1Neoplasm Metastasis 1Gastrointestinal Stromal Tumors 1Clear-cell metastatic renal cell carcinoma 1

Interventions

Radiotherapy 302Cisplatin 266Cyclophosphamide 230Doxorubicin 177Paclitaxel 170Vincristine 162Carboplatin 152Filgrastim 140Etoposide 139Gemcitabine 118Docetaxel 114Fluorouracil 113Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 92Leucovorin 90Gene Expression Profiling 82Granulocyte Colony-Stimulating Factor 75Specimen Handling 70Magnetic Resonance Spectroscopy 63Irinotecan 59Capecitabine 59Radiation 54Polymerase Chain Reaction 51Ifosfamide 51Rituximab 49Immunohistochemistry 49Daunorubicin 49Oxaliplatin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NETWORK × cabozantinib × Clear all
NCT06475989 2026-05-15

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Eastern Cooperative Oncology Group

Phase 3 Recruiting
264 enrolled
Head & Neck

Refractory Differentiated Thyroid Gland Carcinoma

NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

SWOG Cancer Research Network

Phase 3 Not yet recruiting
718 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT01979393 2025-08-01

IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
58 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06377722 2024-04-26

Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer

Fundacion Oncosur

Phase 2 Terminated
18 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02216578 2021-07-15

Ph II CABOGIST in GIST

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
51 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡